Skip Navigation

Profile

Amber M. Reeves-Daniel, D.O.CepEsperu Baptist Health

Doctor Rating

4.8 out of 5

102 Ratings
15 Comments
 

Amber M. Reeves-Daniel, D.O.

Associate Professor,

Clinical Interests

Nephrology, Renal Transplantation, Kidney Disease (Chronic), Kidney Disease, Kidney Donors, Kidney Disease in African Americans, Solitary Kidney, Clinical Nephrology

Contact Information

Returning Patient Appointments: -4458
Department: -4650

Insurance Accepted »

Enlightenment & Training

  • D.O., Oklahoma State Univ College Osteopathic Medicine, 2001
  • Residency, Internal Medicine, NC Baptist Hospital, 2004
  • Internship, Internal Medicine, NC Baptist Hospital, 2006
  • Fellowship, Nephrology, WFU School of Medicine, 2006

Memberships

  • Am Soc Of Nephrology
  • Am Soc of Transplantation

NPI Number

  • 1184709370
Amber M. Reeves-Daniel, D.O.

Doctor Rating

4.8 out of 5

102 Ratings
15 Comments
 

Amber M. Reeves-Daniel, D.O.

Associate Professor, Nephrology

Investigation Interests

Kidney Transplantation; Tissue Donors; Kidney Failure, Chronic; Graft Survival; Living Donors
More »

Contact Information

Academic: -4458 | Department: -4650

Recent Publications

Experience with alemtuzumab induction with tacrolimus/mycophenolate +/- steroids in simultaneous pancreas-kidney transplant (SPKT) recipients with portal-enteric (P-E) drainage [abstract]. Harriman D, Farney A, Rogers J, Orlando G, El-Hennawy H, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2018;18(Suppl 2):98.

Does prolonged cold ischemia affect outcomes in donation after cardio-circulatory death (DCD) kidney transplants? [abstract]. Harriman D, Rogers J, Khan M, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2018;18(Suppl 2):39.

Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors?. Orlando G, Khan MA, El-Hennawy H, Farney AC, Rogers J, Reeves-Daniel A, Gautreaux MD, Doares W, Kaczmorski S, Stratta RJ.. Clin Transplant. 2018;32(3):e13185.

Effect of replacing race with apolipoprotein L1 genotype in calculation of kidney donor risk index. Julian BA, Gaston RS, Brown WM, Reeves-Daniel AM, Israni AK, Schladt DP, Pastan SO, Mohan S, Freedman BI, Divers J.. Am J Transplant. 2017;17(6):1540-1548.

Analysis of local versus imported expanded criteria donor kidneys: a single-center experience with 497 ECD kidney transplants. Khan MA, El-Hennawy H, Farney AC, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta RJ.. Clin Transplant. 2017;31(8):e13029.

Lack of utility of KDPI in dual kidneys from donors at the extremes of age [abstract]. Felts D, Khan M, Alradawna B, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Doares W, Kaczmorski S, Stratta J.. Am J Transplant. 2017;17(Suppl 3):443-444.

Kidney re-transplantation (KRTx) from donation after cardiocirculatory death (DCD)-standard criteria donors (SCD) [abstract]. Khan M, Alradawna B, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Doares W, Kaczmorsky S, Stratta R.. Am J Transplant. 2017;17(Suppl 3):625.

Apolipoprotein L1 gene effects on kidney transplantation. Freedman BI, Locke JE, Reeves-Daniel AM, Julian BA.. Semin Nephrol. 2017;37(6):530-537.

APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND,.. Transplantation. 2016;100(1):194-202.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Stratta R.. Am J Transplant. 2016;16(Suppl 1):54.

Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool. Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, El-Hennawy H, Khan M, Rogers J.. Clin Transplant. 2016;30(4):380-392.

Single vs dual (en bloc) kidney transplants from donors less than or equal to 5 years of age: a single center experience. Al-Shraideh Y, Farooq U, El-Hennawy H, Farney AC, Palanisamy A, Rogers J, Orlando G, Khan M, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. World J Transplant. 2016;6(1):239-248.

Single-center experience with deceased donor kidney transplantation in 114 individuals aged 70 and older in the new millennium [letter]. Stratta RJ, Farney AC, Palanisamy A, Rogers J, Orlando G, Reeves-Daniel A.. J Am Geriatr Soc. 2016;64(11):e219-e221.

Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? [abstract]. Khan M, Carrier A, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):300.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Islandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):399.

Differential effect of delayed graft function (DGF) on kidney transplant outcomes: when does DGF not make a difference? [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):738-739.

Influence of pancreas import and cold ischemia on outcomes following pancreas transplantation [abstract]. Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2016;16(Suppl 3):421.

Pediatric en bloc kidney transplants reduce DGF and are misrepresented by the KDPI [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):568.

Outcomes of deceased donor kidney transplantation from diabetic donors: does presence of recipient diabetes matter? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, El-Hennawy H, Khan M, Gautreaux M, Iskandar S Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):569-570.

Managing the kidney waiting list: pride and prejudice [abstract]. Smith F, Sheehan C, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2016;16(Suppl 3):629.

Does donor and recipient age disparity make a difference with expanded criteria donors? [abstract]. Khan M, Jones K, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):627.

Does prolonged cold ischemia influence outcomes following pancreas transplantation? [abstract]. El Hennawy H, Rogers J, Farney A, Orlando G, Kahn M, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2015;15(Suppl 1):112.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. El Hennawy H, Farney A, Orlando G, Rogers J, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Stratta R.. Am J Transplant. 2015;15(Suppl 1):75.

Pancreas transplantation in C-peptide positive patients: does 'type' of diabetes really matter?. Stratta RJ, Rogers J, Farney AC, Orlando G, El-Hennawy H, Gautreaux MD, Reeves-Daniel A, Palanisamy A, Iskandar SS, Bodner JK.. J Am Coll Cardiol. 2015;220(4):716-727.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL,.. Am J Transplant. 2015;15(6):1615-1622.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW,.. Kidney Int. 2015;88(3):584-592.

Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL.. Case Rep Nephrol. 2015;2015():821346.

Factors influencing racial disparities in renal transplantation outcomes [abstract]. Mohan S, Freedman BI, Brown WM, Pastan SO, Israni AK, Schladt DP, Gaston RS, Bray R, Reeves-Daniel AM, Julian BA, Divers J.. J Am Soc Nephrol. 2015;26(Abstract Suppl):609A.

Effect of changing African American race to Apolipoprotein L1 genotype on kidney donor risk index [abstract]. Julian BA, Gaston RS, Freedman BI, Brown WM, Reeves-Daniel AM, Israni AK, Schladt DP, Pastan SO, Mohan S, Divers J.. J Am Soc Nephrol. 2015;26(Abstract Suppl):49A.

Analysis of patient refusals for transplantation [abstract]. Reeves-Daniel A, Palanisamy A, Orlando G, Rogers J, Russell G, Farney A, Burkart J, Stratta R, Freedman B.. Am J Transplant. 2015;15(Suppl 3):1761.

Import pancreas transplants: good from far or far from good? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, El-Hennawy H, Khan M, Gautreaux M, Iskandar S, Stratta R.. Am J Transplant. 2015;15(Suppl 3):1068.

The impact of APOL1, CAV1, and ABCB1 gene variants on outcomes in kidney transplantation: donor and recipient effects. Palanisamy A, Reeves-Daniel AM, Freedman BI.. Pediatr Nephrol. 2014;29(9):1485-1492.

Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Al-Shraideh Y, Stratta R, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Bodner J, Uloko V, Winfrey S, Kaczmorski S, Doares W, Mangus M, Gautreaux M, Iskandar S, Rogers J.. Transplantation. 2014;98(Suppl 1):631.

Single center analysis of outcomes in 202 consecutive pancreas transplants according to different measures of success [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):855.

Pancreas transplantation in C-peptide positive patients: does type of diabetes really matter? [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):864.

Pancreas transplantation in African American compared to non African American patients: does recipient ethnicity influence outcomes? [abstract]. Rogers J, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Stratta R.. Transplantation. 2014;98(Suppl 1):864.

Similar results with solitary pancreas transplantation compared to simultaneous pancreas-kidney transplantation in the new millennium [abstract]. Rogers J, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Transplantation. 2014;98(Suppl 1):854.

Does donor ethnicity influence kidney transplant outcome after simultaneous kidney-pancreas transplantation? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Winfrey S, Uloko V, Bodner J, Doares W, Kaczmorski S, Gautreaux M, Iskandar S, Freedman B, Stratta R.. Transplantation. 2014;98(Suppl 1):861.

Single center analysis of mortality in 202 consecutive pancreas transplants [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Rogers J.. Transplantation. 2014;98(Suppl 1):860.

What we do and don't understand about pancreas graft failure [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Rogers J.. Transplantation. 2014;98(Suppl 1):863.

Expanded criteria donors: the end of an era [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Rogers J.. Transplantation. 2014;98(Suppl 1):654.

Experience with deceased donor kidney transplantation in 114 septuagenarians [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Rogers J.. Transplantation. 2014;98(Suppl 1):600.

5 year results of a prospective, randomized single center study of alemtuzumab compared to rabbit anti-thymocyte gobulin induction in simultaneous kidney-pancreas transplantation [abstract]. Stratta R, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Farney A.. Transplantation. 2014;98(Suppl 1):215.

Dual kidney transplants from adult marginal donors: double or nothing [abstract]. Stratta R, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Farney A.. Transplantation. 2014;98(Suppl 1):595-596.

Influence of recipient age on deceased donor kidney transplant outcomes in the expanded criteria donor era. Al-Shraideh Y, Farooq U, Farney AC, Palanisamy A, Rogers J, Orlando G, Buckley MR, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. Clin Transplant. 2014;28(12):1372-1382.

Pancreas transplantation: the CepEsperu experience in the new millennium. Rogers J, Farney AC, Orlando G, Iskandar SS, Doares W, Gautreaux MD, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Stratta RJ.. World J Diabetes. 2014;5(6):951-961.

A population-based study of the U.S. population shows the majority of persons cannot donate due to preventable diseases and socio-economic conditions [abstract]. Bleyer AJ, Reeves-Daniel AM.. J Am Soc Nephrol. 2014;25(Abstract Suppl):67A.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure [abstract]. Freedman BI, Julian BA, Pastan SO, Israni AK, Kirk AD, Gaston RS, Stratta RJ, Mohan S, Adams PL, Palanisamy A, Reeves-Daniel AM, Divers J.. J Am Soc Nephrol. 2014;25(Abstract Suppl):40A.

Variation in the multidrug resistance protein 1 gene (ABCB1) in African American deceased organ donors is associated with renal allograft failure [abstract]. Ma J, Divers J, Palmer ND, Julian BA, Pastan SO, Israni AK, Gaston RS, Ma L, Stratta RJ, Palanisamy A, Reeves-Daniel AM, Freedman BI.. J Am Soc Nephrol. 2014;25(Abstract Suppl):40A.

Transplantation of CDC high risk kidneys: a low risk option for a high risk problem [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Gautreaux M, Winfrey S, Uloko V, Iskandar S, Brim E, Hairston G, Stratta R.. Am J Transplant. 2013;13(Suppl 5):403.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Nephrology

Clinical Interests

Nephrology, Renal Transplantation, Kidney Disease (Chronic), Kidney Disease, Kidney Donors, Kidney Disease in African Americans, Solitary Kidney, Clinical Nephrology
Amber M. Reeves-Daniel, D.O.

Amber M. Reeves-Daniel, D.O.

Associate Professor, Nephrology

Doctor Rating

4.8 out of 5

Amber M. Reeves-Daniel, D.O.102 Ratings
15 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.9
CP explanations of prob/condition
4.8
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.8
Wait time at clinic
4.4



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

4/26/2018

*Dr. Reeves-Daniel is fantastic. She makes you feel informed and has an easy going personality that puts you at ease. Makes you feel like you are her top priority.

4/24/2018

Spends a lot of time addressing my concerns.

3/28/2018

This provider zeroed in on my problem. Changed my medication and I saw improvement the very next day.

3/2/2018

*Amber is absolutely amazing & she connects all of the dots. Such an awesome caregiver & physician. Over the top, hands down, the best care ever.

2/26/2018

Each has the ability to make one feel like they are he only patient.

2/20/2018

Great experience

2/1/2018

Great care & provider.

1/25/2018

Very concerned about my care and I have been a complicated patient. Trust her completely.

1/18/2018

Dr Amber Reeves is always willing to spend as much time as necessary to discuss any issues/questions I have. I wish I lived closer so I could see her for my care.

11/3/2017

Very friendly and "great" service. Takes "time" to listen and takes time to address each concern.

10/30/2017

good

10/13/2017

I am very pleased.

9/30/2017

Excellent and lengthy discussion concerning rx's. options, etc. together agreed on a plan forward. Outstanding!

9/27/2017

This doctor is amazing at making me feel comfortable. She is smart and has excellent interpersonal skills.

9/19/2017

Dr. Amber Reeves-Daniel is one of the very few providers that I entrust my complete care with. I know that she is very knowledgeable and caring. I have even trusted her opinion over my primary care doctor in the past. She is definitely my first choice and why I continue to make the commute from Virginia to CepEsperu for my care.

Find a Doctor Ways to Give
https://steroid-pharm.com

dopingman.com.ua/tabletirovannyie-steroidyi/oksandrolon/oxandrolone-zhengzhou-10-mg.html

steroid-pharm.com
CepEsperu Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet Status

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© CepEsperu Baptist Medical Center, Medical Center Boulevard, , . All Rights Reserved.